Event-Driven Stocks

ILLUMINA, INC.

ILMNNasdaq

Healthcare · Laboratory Analytical Instruments · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 4 good● 1 warningdetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY19
Revenue$4.34B$4.37B$4.50B$4.53B$3.24B$3.54B
Operating income$807.0M−$833.0M−$1.07B−$123.0M$580.0M$985.0M
Net income$850.0M−$1.22B−$1.16B$762.0M$656.0M$1.00B
Total assets$6.64B$6.30B$10.11B$15.22B$7.58B$7.32B
Total liabilities——————
Equity$2.72B$2.37B$6.60B$10.74B$4.69B$4.61B
EPS (diluted)$5.45$-7.69$-7.34$5.04$4.45$6.74
Shares out.158.4M158.9M158.0M157.0M145.9M147.0M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
18.6%
Net margin
19.6%
Return on equity
31.2%
Return on assets
12.8%
Return on capital (ROCE)
16.0%
Liabilities / assets
—
Debt / equity
—
Book value / share
$17.19
Revenue growth (YoY)
−0.7%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Accruals / assets
−3.4%clean
Piotroski F-Score
7/8strong

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
67
/ 100
Profitability 100Growth 0Catalyst 33Earnings quality 100Financial strength 100

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 1 warning● 4 good
  • Revenue declined year-over-year
  • Operating margin is positive
  • Strong return on equity (>15%)
  • Positive operating cash flow
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 20267.5M4.0+14.6%
Apr 30, 20266.5M4.7-8.8%
Apr 15, 20267.2M5.2+3.2%
Mar 31, 20267.0M4.9-3.8%
Mar 13, 20267.2M4.5+0.9%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Corporate family

Spin-offs from ILLUMINA, INC. (1)

From the spin-off filings we track. Follow a company to walk its own history.

Event-driven situations (2)